Clinical Trial Update: TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

View source ↗

Summary

This clinical trial update describes the TRAMmoniTTR study, a genetic screening program for individuals at risk of hereditary transthyretin amyloidosis and moni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Hereditary Transthyretin-mediated Amyloidosis with Cardiomyopathy
• Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy
• Polyneuropathy
• Transthyretin Amyloidosis

Snippet

Sponsor: CENTOGENE GmbH Rostock | Conditions: Transthyretin Amyloidosis, Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Status: COMPLETED